Evidence map›Paper›PMID 21248039›Full record

ArticleJournal of virology2011

The herpes simplex virus immediate-early ubiquitin ligase ICP0 induces degradation of the ICP0 repressor protein E2FBP1.

Yayoi Fukuyo, Nobuo Horikoshi, Alexander M Ishov, Saul J Silverstein, Takuma Nakajima

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 2 countries.

Yayoi FukuyoCalifornia Pacific Medical Center Research Institute, 475 Brannan Street, Suite 220, San Francisco, California 94107, USA.
Nobuo Horikoshi
Alexander M Ishov
Saul J Silverstein
Takuma Nakajima
California Pacific Medical Center · USColumbia University · USFlorida College · USThe University of Texas Southwestern Medical Center · USTokyo Medical and Dental University · JP

Funding

VZ VIRUS: CLINICAL IMPLICATIONS OF IMMUNITYR01AI024021 · NIAID · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI SILVERSTEIN, SAUL J · 1986 to 2008
$3.0M
Function of Daxx in mitosis that determines paclitaxel sensitivity in breast cancR01CA127378 · NCI · UNIVERSITY OF FLORIDA · PI ISHOV, ALEXANDER M · 2007 to 2011
$1.4M
Varicella Zoster Virus:Clinical Implications of ImmunityR21AI024021 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SILVERSTEIN, SAUL J · 2003 to 2003
$363k
NCI NIH HHS CA127378-01A1NCI NIH HHS R01 CA127378NIAID NIH HHS AI024021NIAID NIH HHS R01 AI024021NIAID NIH HHS R21 AI024021
6 · The paper itself

Abstract

E2FBP1/hDRIL1, a DNA-binding A/T-rich interaction domain (ARID) family transcription factor, is expressed ubiquitously in human tissues and plays an essential role in maintaining the proliferation potential of passage-limited human fibroblasts by dissociating promyelocytic leukemia nuclear bodies (PML-NBs). This effect on PML-NBs is similar to that of viral immediate-early gene products, such as infected cellular protein 0 (ICP0) from human herpes simplex virus 1 (HSV-1), which also disrupts PML-NBs to override the intrinsic cellular defense. Here we report that E2FBP1 inhibits accumulation of ICP0 RNA and, at the same time, is degraded via ICP0's herpes ubiquitin ligase 2 (HUL-2) activity upon HSV-1 infection. These reciprocal regulatory roles of ICP0 and E2FBP1 are linked in an ARID-dependent fashion. Our results suggest that E2FBP1 functions as an intrinsic cellular defense factor in spite of its PML-NB dissociation function.

Indexed as

Host-Pathogen InteractionsCell LineDNA-Binding ProteinsHerpesvirus 1, HumanHumansImmediate-Early ProteinsRepressor ProteinsTranscription FactorsUbiquitin-Protein LigasesVirulence FactorsARID3A protein, humanDNA-Binding ProteinsImmediate-Early ProteinsRepressor ProteinsTranscription FactorsUbiquitin-Protein LigasesVirulence FactorsVmw110 protein, Human herpesvirus 1

Identifiers

PMID21248039
PMCPMC3067832
OpenAlexW2095012384

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.